The institutional affiliation of Flavio A. Cadegiani was incorrectly listed as ‘Federal University of São Paulo’ in the following articles: ‘5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia’1; ‘Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19’2; ‘Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men’3; ‘Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients’.4
This should be corrected as follows:
Flavio A. Cadegiani 1,2
1Corpometria Institute, Brasilia, DF, Brazil.
2Applied Biology Inc, Irvine, CA, USA.
References
- 1.McCoy J, Cadegiani FA, Wambier CGet al. 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia. J Eur Acad Dermatol Venereol 2021; 35: e243–e307. [DOI] [PubMed] [Google Scholar]
- 2.Cadegiani FA, Lim RK, Goren Aet al. Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19. J Eur Acad Dermatol Venereol 2021; 35: e97–e163. [DOI] [PubMed] [Google Scholar]
- 3.Goren A, Wambier CG, Herrera Set al. Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men. J Eur Acad Dermatol Venereol 2021; 35: e1–e96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.McCoy J, Wambier CG, Herrera Set al. Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients. J Eur Acad Dermatol Venereol. 2021; 35: e1–e96. [DOI] [PMC free article] [PubMed] [Google Scholar]